# Darbepoetin in Neonatal Encephalopathy Trial

> **NCT04432662** · PHASE2 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 150 (estimated)

## Conditions studied

- Neonatal Encephalopathy

## Interventions

- **DRUG:** Darbepoetin Alfa

## Key facts

- **NCT ID:** NCT04432662
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-28
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04432662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04432662, "Darbepoetin in Neonatal Encephalopathy Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04432662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*